help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on February 7, 2006
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2005-2135
A more recent version of this article appeared on April 1, 2006
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
91/4/1586    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moriconi, N.
Right arrow Articles by Puder, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moriconi, N.
Right arrow Articles by Puder, J. J.

Submitted on September 26, 2005
Accepted on January 30, 2006

Body composition and adiponectin serum concentrations in adult patients with cystic fibrosis

Natascha Moriconi, Marius Kraenzlin, Beat Müller, Ulrich Keller, Charly P. G. Nusbaumer, Susie Stöhr, Michael Tamm, and Jardena J. Puder*

Division of Endocrinology, Diabetes and Clinical Nutrition (NM, MK, BM, UK, JJP), Division of Central Laboratory (CPGN), Clinic of Pulmonary Medicine (SS, MT), University Hospital, CH-4031 Basel, Switzerland & Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York 10032 (JJP)

* To whom correspondence should be addressed. E-mail: Puderj{at}uhbs.ch.

Context: Cystic fibrosis (CF) is a disease characterized by weight loss and chronic low-grade inflammation.

Objective: To assess changes in body composition and in the serum concentrations of adiponectin, a marker of negative energy balance and of insulin sensitivity, in adult patients with CF.

Design: Cross-sectional study.

Setting: Outpatient clinic of the University Hospital of Basel, Switzerland.

Participants: 24 stable adult CF patients and 24 healthy controls, matched for body mass index (BMI), age, sex and hormonal therapy in women.

Main Outcome Measures: Changes in body composition (assessed by dual x-ray absorptiometry) and in serum adiponectin levels.

Results: BMI, % fat mass (in percentage of body weight) and % lean body mass were similar in patients and controls, while central fat accumulation was increased [trunk to extremity fat ratio 1.2 (0.99-1.51) vs. 0.99 (0.81-1.25), P = 0.01] in patients with CF compared with controls. Decreased lean mass and increased highly sensitive C-reactive protein (hs-CRP) levels were independently associated with worse lung function in CF patients. Despite similar insulin resistance (HOMA model) and similar SHBG serum concentrations, the serum concentrations of adiponectin were higher in CF patients compared with controls, independent of other confounders (P = 0.01).

Conclusion: Central fat accumulation is increased in patients with CF. It is postulated that the energy deficit-induced increase in serum adiponectin could explain the preservation of insulin sensitivity in these patients in spite of the increase in central fat and in hs-CRP serum concentrations and could prevent a further deterioration of protein catabolism.


Key words: Cystic fibrosis • body composition • inflammation mediators • fat body • adiponectin







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society